A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
MedImmune LLC
GlaxoSmithKline
H. Lee Moffitt Cancer Center and Research Institute
UNICANCER
Leap Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Seoul National University Hospital
GERCOR - Multidisciplinary Oncology Cooperative Group
Barbara Ann Karmanos Cancer Institute
University of Roma La Sapienza
Genentech, Inc.
Sun Yat-sen University
Medical Research Council
University of Louisville
Hospital Universitari de Bellvitge
UNICANCER
UNICANCER
Xiangya Hospital of Central South University
Federation Francophone de Cancerologie Digestive
Federation Francophone de Cancerologie Digestive
Brown University
Alliance for Clinical Trials in Oncology
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Leicester
Sirtex Medical
National Cancer Institute (NCI)
Genentech, Inc.
Memorial Sloan Kettering Cancer Center
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Amgen
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
NYU Langone Health
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)